BORTEZOMIB CIPLA
As listed in the register: BORTEZOMIB CIPLA 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG
3.5 mg · polvo para solución inyectable
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Bortezomib
- Made by
- Cipla Europe
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States17 matching products
Bulgaria6 matching products
- Bortezocon 3.5 mg · powder for solution for injection
- Bortezomib Actavis 3,5 mg · powder for solution for injection
- Bortezomib Rompharm 3.5 mg · powder for solution for injection
- Bortezomib TZF 3,5 mg · powder for solution for injection
- Gloftrinid 3.5 mg · powder for solution for injection
- Vortemyel 3,5 mg · powder for solution for injection
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands17 matching products
- Bortezomib Synthon 3 3,5 mg · poeder voor oplossing voor injectie3 makers
- Bortezomib Accord 3 3,5 mg · poeder voor oplossing voor injectie
- Bortezomib Eugia 3 3,5 mg · poeder voor oplossing voor injectie
- Bortezomib Fresenius Kabi 3 3,5 mg · poeder voor oplossing voor injectie
- Bortezomib Glenmark 3 3,5 mg · poeder voor oplossing voor injectie
- Bortezomib medac 3 3,5 mg · poeder voor oplossing voor injectie
- BORTEZOMIB MSN 3 3,5 mg · poeder voor oplossing voor injectie
- Bortezomib Sandoz 3 3,5 mg · poeder voor oplossing voor injectie
SwitzerlandNo exact match for this strength and form
Details
| Made by | Cipla Europe |
|---|---|
| Active substance | Bortezomib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 3.5 mg |
| Form | polvo para solución inyectable |
| Classification | L01XG01 · Cancer treatments and immune-system medicines |
| Route | vía intravenosa, vía subcutánea |
| Marketed | No — authorised but not currently marketed, according to the register |
| Generic | Yes — a generic medicine, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | BORTEZOMIB CIPLA 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG |
| Nº Registro | 85658 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.